ATLANTA, GA--(MARKET WIRE)--Jul 6, 2006 -- AtheroGenics, Inc. (Nasdaq:AGIX - News), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced the promotion of Joseph M. Gaynor, Jr. to Senior Vice President and General Counsel.
